Benjamin Haffemayer, PhD, is an experienced professional in Global Pricing and Market Access, currently serving as Executive Director and Therapeutic Head for Global Value & Access in General Medicine. Haffemayer has a proven record of successful launches for innovative and biosimilar products across various therapeutic areas and geographies. Previously, they held leadership roles at Amgen, where they managed access strategies for oncology brands and biosimilars, and contributed to significant pricing and policy shaping initiatives. Haffemayer obtained a PhD in Chemistry from the University of Cambridge and has a strong background in research and development from positions held at Merck Group, Pfizer, and Servier.
This person is not in the org chart
This person is not in any teams
This person is not in any offices